123 related articles for article (PubMed ID: 36739621)
1. NLX-101, a 5-HT
Aguiar RP; Soares LM; Varney M; Newman-Tancredi A A; Milani H; Prickaerts J; de Oliveira RMW
Neurobiol Aging; 2023 Apr; 124():52-59. PubMed ID: 36739621
[TBL] [Abstract][Full Text] [Related]
2. Biased 5-HT
van Hagen BTJ; van Goethem NP; Nelissen E; Paes D; Koymans K; van Hoof S; Schreiber R; Varney M; Newman-Tancredi A; Prickaerts J
Mol Cell Neurosci; 2022 May; 120():103719. PubMed ID: 35283305
[TBL] [Abstract][Full Text] [Related]
3. NLX-101, a highly selective 5-HT
Depoortère R; Auclair AL; Newman-Tancredi A
Behav Brain Res; 2021 Mar; 401():113082. PubMed ID: 33358917
[TBL] [Abstract][Full Text] [Related]
4. Activation of 5-HT
Aguiar RP; Soares LM; Meyer E; da Silveira FC; Milani H; Newman-Tancredi A; Varney M; Prickaerts J; Oliveira RMW
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109832. PubMed ID: 31809832
[TBL] [Abstract][Full Text] [Related]
5. Effects of the Serotonin 5-HT
Newman-Tancredi A; Varney MA; McCreary AC
Neurochem Res; 2018 May; 43(5):1035-1046. PubMed ID: 29572645
[TBL] [Abstract][Full Text] [Related]
6. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.
Iderberg H; McCreary AC; Varney MA; Cenci MA; Newman-Tancredi A
Neuropharmacology; 2015 Jun; 93():52-67. PubMed ID: 25645393
[TBL] [Abstract][Full Text] [Related]
7. Divergent effects of the 'biased' 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task.
van Goethem NP; Schreiber R; Newman-Tancredi A; Varney M; Prickaerts J
Br J Pharmacol; 2015 May; 172(10):2532-43. PubMed ID: 25572672
[TBL] [Abstract][Full Text] [Related]
8. Activity of Serotonin 5-HT
Jastrzębska-Więsek M; Partyka A; Rychtyk J; Śniecikowska J; Kołaczkowski M; Wesołowska A; Varney MA; Newman-Tancredi A
ACS Chem Neurosci; 2018 May; 9(5):1040-1050. PubMed ID: 29266914
[TBL] [Abstract][Full Text] [Related]
9. Marble Burying in NMRI Male Mice Is Preferentially Sensitive to Pre- Versus Postsynaptic 5-HT1A Receptor Biased Agonists.
Depoortere R; Bardin L; Auclair AL; Bruins Slot LA; Newman-Tancredi A
Pharmacology; 2021; 106(1-2):114-118. PubMed ID: 32950991
[TBL] [Abstract][Full Text] [Related]
10. Translating biased agonists from molecules to medications: Serotonin 5-HT
Newman-Tancredi A; Depoortère RY; Kleven MS; Kołaczkowski M; Zimmer L
Pharmacol Ther; 2022 Jan; 229():107937. PubMed ID: 34174274
[TBL] [Abstract][Full Text] [Related]
11. Serotonin 5-HT
Depoortère R; Bardin L; Varney MA; Newman-Tancredi A
ACS Chem Neurosci; 2019 Jul; 10(7):3101-3107. PubMed ID: 30929419
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological MRI to investigate the functional selectivity of 5-HT
Vidal B; Bolbos R; Redouté J; Langlois JB; Costes N; Newman-Tancredi A; Zimmer L
Neuropharmacology; 2020 Aug; 172():107867. PubMed ID: 31783063
[TBL] [Abstract][Full Text] [Related]
13. The selective 5-HT
Głuch-Lutwin M; Sałaciak K; Gawalska A; Jamrozik M; Sniecikowska J; Newman-Tancredi A; Kołaczkowski M; Pytka K
Psychopharmacology (Berl); 2021 Aug; 238(8):2249-2260. PubMed ID: 33973045
[TBL] [Abstract][Full Text] [Related]
14. Serotonin 5-HT
Levigoureux E; Vidal B; Fieux S; Bouillot C; Emery S; Newman-Tancredi A; Zimmer L
ACS Chem Neurosci; 2019 Jul; 10(7):3108-3119. PubMed ID: 30576601
[TBL] [Abstract][Full Text] [Related]
15. The 5-HT
Głuch-Lutwin M; Sałaciak K; Pytka K; Gawalska A; Jamrozik M; Śniecikowska J; Kołaczkowski M; Depoortère RY; Newman-Tancredi A
Behav Brain Res; 2023 Feb; 438():114207. PubMed ID: 36368443
[TBL] [Abstract][Full Text] [Related]
16. Anti-aggressive effects of the selective high-efficacy 'biased' 5-HT₁A receptor agonists F15599 and F13714 in male WTG rats.
de Boer SF; Newman-Tancredi A
Psychopharmacology (Berl); 2016 Mar; 233(6):937-47. PubMed ID: 26694810
[TBL] [Abstract][Full Text] [Related]
17. The 5-HT
Papp M; Gruca P; Lason M; Litwa E; Newman-Tancredi A; Depoortère R
Psychopharmacology (Berl); 2023 Nov; 240(11):2419-2433. PubMed ID: 37310446
[TBL] [Abstract][Full Text] [Related]
18. Activation of somatodendritic 5-HT
Zhao Y; Bijlsma EY; Ter Heegde F; Verdouw MP; Garssen J; Newman-Tancredi A; Groenink L
Psychopharmacology (Berl); 2019 Apr; 236(4):1171-1185. PubMed ID: 30539269
[TBL] [Abstract][Full Text] [Related]
19. Distinctive in vitro signal transduction profile of NLX-112, a potent and efficacious serotonin 5-HT
Newman-Tancredi A; Martel JC; Cosi C; Heusler P; Lestienne F; Varney MA; Cussac D
J Pharm Pharmacol; 2017 Sep; 69(9):1178-1190. PubMed ID: 28612503
[TBL] [Abstract][Full Text] [Related]
20. The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements.
McCreary AC; Varney MA; Newman-Tancredi A
Neuropharmacology; 2016 Jun; 105():651-660. PubMed ID: 26777281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
